Dr. Jiang Liu is the Associate Director for Therapeutic Reviews of the Division of Pharmacometrics, Office of Clinical Pharmacology, Center of Drug Evaluation and Research, at the U.S. Food and Drug Administration. Dr. Liu received his PhD in pharmaceutical sciences and master’s in statistics from the University of Florida. He joined the FDA as a pharmacometrics reviewer more than 14 years ago. Dr. Liu had also served as a QT-IRT scientific lead for three years and a pharmacometrics team leader for four years before taking his current role. He is overseeing pharmacometrics review activities focusing on oncology, immunology, rare diseases, etc.